The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
NeoGenomics Inc. | COM NEW | 64049M209 | 19,613 | 1,614,263 | SH | SOLE | 1,614,263 | 0 | 0 | ||
Horizon Therapeutics Public Limited Company | SHS | G46188101 | 57,322 | 544,835 | SH | SOLE | 544,835 | 0 | 0 | ||
Vericel Corporation | COM | 92346J108 | 21,133 | 552,925 | SH | SOLE | 552,925 | 0 | 0 | ||
Five9, Inc. | COM | 338307101 | 18,361 | 166,310 | SH | SOLE | 166,310 | 0 | 0 | ||
ISHARES TR | CORE 1 5 YR USD | 46432F859 | 108 | 2,228 | SH | SOLE | 2,228 | 0 | 0 | ||
ISHARES TR | CORE S&P500 ETF | 464287200 | 106 | 234 | SH | SOLE | 234 | 0 | 0 | ||
ISHARES TR | CORE MSCI EAFE | 46432F842 | 26,473 | 380,847 | SH | SOLE | 380,847 | 0 | 0 | ||
ISHARES TR | CORE INTL AGGR | 46435G672 | 45 | 862 | SH | SOLE | 862 | 0 | 0 | ||
ISHARES TR | CR 5 10 YR ETF | 46435G417 | 39 | 834 | SH | SOLE | 834 | 0 | 0 | ||
ISHARES TR | CORE S&P MCP ETF | 464287507 | 33 | 122 | SH | SOLE | 122 | 0 | 0 | ||
ISHARES TR | CORE MSCI EMKT | 46434G103 | 16,933 | 304,825 | SH | SOLE | 304,825 | 0 | 0 | ||
ISHARES TR | CORE S&P SCP ETF | 464287804 | 18 | 169 | SH | SOLE | 169 | 0 | 0 | ||
JAMF HOLDING CORP | COM | 47074L105 | 21,388 | 614,410 | SH | SOLE | 614,410 | 0 | 0 | ||
MITEK SYS INC | COM NEW | 606710200 | 3,479 | 237,128 | SH | SOLE | 237,128 | 0 | 0 |